EGFR and melanoma: In a different set of melanoma cell lines, Sun et al [19] found that acquired resistance to vemurafenib was associated with a strong down-regulation of miR-7 and up-regulation of its targets epidermal growth factor receptor (EGFR), insulin-like growth factor-1 receptor (IGF-1R) and CRAF.